top of page
Nov 16, 2022
PROXIDRUGS project leaders Ivan Đikić and Stefan Knapp are Highly Cited Researchers 2022
The list of Highly Cited Researchers identifies pioneers in their respective fields who repeatedly demonstrated significant and broad...
Oct 19, 2022
Commentary: Localization matters!
In the latest issue of Cell Chemical Biology, PROXIDRUGS scientists Varun Shah and Ivan Đikić comment on an article published by Simpson...
Oct 19, 2022
Successful PROXIDRUGS annual meeting
On October 17th and 18th, the second annual PROXIDRUGS meeting took place in Bad Brückenau. Exciting research results were presented, and...
Sep 21, 2022
EMBO Workshop “Cancer cell signaling: Linking molecular knowledge on cancer therapy”
The PROXIDRUGS consortium actively took part in the EMBO Workshop “Cancer cell signaling: Linking molecular knowledge on cancer therapy”...
Aug 31, 2022
Fraunhofer Research News featuring the PROXIDRUGS consortium
In a press release issued by Fraunhofer Society, the PROXIDRUGS consortium is introduced to the broad public. PROXIDRUGS project leader...
Jul 4, 2022
beLAB 2122: Translational BRIDGE partnership to develop bifunctional degrader
A oncology project from Goethe University was now chosen for funding within the beLAB2122 BRIDGE partnership. On the academic side, the...
Jun 7, 2022
1st German Chemical Biology Lecturship
The German Chemical Biology Lectureship is awarded by the Joint Working Group Chemical Biology to outstanding young scientists to honor...
Apr 26, 2022
Third ERC Advanced Grant to Ivan Đikić
PROXIDRUGS speaker Ivan Đikić has been awarded with an Advanced Grant of the European Research Council (ERC). This is the third time he...
Mar 31, 2022
FCI Professorship for PROXIDRUGS member Manuel Kaulich
InnoTECH scientist Manuel Kaulich was appointed as FCI professor for autophagy in tumor pathogenesis as part of the LOEWE Center...
Mar 16, 2022
Whitepaper: Strategic collaboration between academia and industry enables drug discovery
Ivan Đikić, Aimo Kannt and Kerstin Koch, all members of the PROXIDRUGS consortium, s hare their views on how strategic collaboration has...
bottom of page